57 research outputs found
Interleukin 10 promoter haplotype is associated with alcoholic liver cirrhosis in Taiwanese patients
AbstractAlcoholic liver cirrhosis is a severe form of alcohol-related liver damage. More than 95% of heavy drinkers develop a fatty liver, but only 35% of them develop cirrhosis. We postulate that genetic factors may play a role in this difference. Genetic polymorphisms of the cytokine genes may influence Kupffer cells cytokine genes expression. In this study, we evaluated the promoter polymorphisms of interleukin (IL) 1Ξ², IL 6, IL 10, and tumor necrosis factor alpha (TNFΞ±) and aimed to clarify the association between the polymorphisms and the disease. Forty alcoholic patients with liver cirrhosis and 64 healthy volunteers were included in our investigation. Genotyping on IL 1Ξ² β511 T>C, IL 6 β572 G>C, IL 10 β819 C>T, IL 10 β1082 G>A, and TNFΞ± β308 G>A was done. Another 36 patients with recurrent alcoholic pancreatitis were included as an additional control group. Genotyping on IL 10 β819 C>T and IL 10 β1082 G>A was done. The polymorphisms on IL 1 and IL 6 showed no significant association. The p value for TNFΞ± β308 G>A was 0.028 in comparison with healthy volunteers. Although the p value was less than 0.05, it did not reach significance after Bonferroni correction. The p values for IL 10 β819 C>T and IL 10 β1082 G>A were respectively 0.031 and 0.026 in healthy volunteers and 0.028 and 0.023 in the alcoholic pancreatitis group. The results also did not reach significance after Bonferroni correction. Among the participants with the GCC haplotype, healthy volunteers had pΒ =Β 0.027 (pΒ <Β 0.05) and an odds ratio (OR) of 0.124 [confidence interval (95%) CI, 0.015β0.997], whereas the alcoholic pancreatitis group had pΒ =Β 0.023 (pΒ <Β 0.05) and an OR of 0.106 (95% CI, 0.012β0.912). The odds ratio of people having one ATA haplotype was 6.233 (95% CI, 0.739β52.547) in healthy volunteers and 6.588 (95% CI, 0.727β59.679) in the alcoholic pancreatitis group; the corresponding rate was 10.521 (95% CI, 1.252β88.440) and 12.833 (95% CI 1.408β117.008) for people with two ATA haplotypes. The p values in these groups were 0.031 (pΒ <Β 0.05) and 0.028 (pΒ <Β 0.05), respectively. The presence of a GCC haplotype could have protective effect against alcoholic liver disease, whereas the presence of an ATA haplotype could predispose carriers to the disease. The IL 10 promoter haplotype is associated with alcoholic liver cirrhosis in Taiwanese patients
ΠΠ²ΠΎΠ»ΡΡΠΈΡ Π½Π°Π½ΠΎΡΡΡΡΠΊΡΡΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ ΠΏΡΠΎΠ΄ΡΠΊΡΠΎΠ² ΠΈΠ½Π΄ΠΈΠ²ΠΈΠ΄ΡΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠ»Π΅ΠΊΡΡΠΎΡ ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΎΠΊΠΈΡΠ»Π΅Π½ΠΈΡ ΠΌΠ΅Π΄ΠΈ ΠΈ Π°Π»ΡΠΌΠΈΠ½ΠΈΡ
This paper covers the results of the composition and structure evolution of nanostructured materials produced by separate electrochemical oxidation of metals (copper and aluminum). The electrolysis products after short-term and long-term aging were characterized by XRD (Xβray diffraction) and DSC (differential scanning calorimetry) analysis. There is the difference in aging of nanostructures of copper- and aluminum-compounds. Short-term aging results in the phase transformation of copper (I) oxide and the stability of aluminum oxyhydroxide (boehmite). Copper (I) oxide is oxidized to copper (II) oxide and copper carbonate hydroxide. At long-term aging the oxidation of copper (I) oxide does not completed because the PillingβBedworth ratio for copper (II) oxide, copper carbonate hydroxide is greater than one. The structure of all copper-containing compounds (copper (I) oxide, copper (II) oxide, copper carbonate hydroxide) is changed. It results in the increases of both the interplanar spacing and the temperature of the phase transformations. Coherent scattering region (CSR) of boehmite and copper (I) oxide are 3β4 nm and 20β30 nm, respectively, and does not change at short-term and long-term agingΠ ΡΠ°Π±ΠΎΡΠ΅ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Ρ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΡΠ²ΠΎΠ»ΡΡΠΈΠΈ ΡΠΎΡΡΠ°Π²Π° ΠΈ ΡΡΡΡΠΊΡΡΡΡ
Π½Π°Π½ΠΎΡΡΡΡΠΊΡΡΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΠΌΠ°ΡΠ΅ΡΠΈΠ°Π»ΠΎΠ², ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ
ΠΏΡΠΈ ΡΠ°Π·Π΄Π΅Π»ΡΠ½ΠΎΠΌ ΡΠ»Π΅ΠΊΡΡΠΎΡ
ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΎΠΌ ΠΎΠΊΠΈΡΠ»Π΅Π½ΠΈΠΈ
ΠΌΠ΅ΡΠ°Π»Π»ΠΎΠ² (ΠΌΠ΅Π΄Ρ ΠΈ Π°Π»ΡΠΌΠΈΠ½ΠΈΠΉ). ΠΡΠΎΠ΄ΡΠΊΡΡ ΡΠ»Π΅ΠΊΡΡΠΎΠ»ΠΈΠ·Π° ΠΏΠΎΡΠ»Π΅ ΠΊΡΠ°ΡΠΊΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΠ³ΠΎ ΠΈ Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ
ΡΡΠ°ΡΠ΅Π½ΠΈΡ ΠΎΡ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΠ·ΠΎΠ²Π°Π½Ρ ΠΌΠ΅ΡΠΎΠ΄Π°ΠΌΠΈ Π Π€Π (ΡΠ΅Π½ΡΠ³Π΅Π½ΠΎΡΠ°Π·ΠΎΠ²ΡΠΉ Π°Π½Π°Π»ΠΈΠ·) ΠΈ ΠΠ‘Π (Π΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΠ°Π»ΡΠ½Π°Ρ
ΡΠΊΠ°Π½ΠΈΡΡΡΡΠ°Ρ ΠΊΠ°Π»ΠΎΡΠΈΠΌΠ΅ΡΡΠΈΡ). Π£ΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΎ ΡΠ°Π·Π»ΠΈΡΠΈΠ΅ Π² ΡΡΠ°ΡΠ΅Π½ΠΈΠΈ Π½Π°Π½ΠΎΡΡΡΡΠΊΡΡΡ ΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΠΉ ΠΌΠ΅Π΄ΠΈ
ΠΈ Π°Π»ΡΠΌΠΈΠ½ΠΈΡ. ΠΡΠ°ΡΠΊΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΠ΅ ΡΡΠ°ΡΠ΅Π½ΠΈΠ΅ ΠΏΡΠΈΠ²ΠΎΠ΄ΠΈΡ ΠΊ ΡΠ°Π·ΠΎΠ²ΠΎΠΌΡ ΠΏΡΠ΅Π²ΡΠ°ΡΠ΅Π½ΠΈΡ ΠΎΠΊΡΠΈΠ΄Π° ΠΌΠ΅Π΄ΠΈ (I)
ΠΈ ΡΡΠ°Π±ΠΈΠ»ΡΠ½ΠΎΡΡΠΈ ΠΎΠΊΡΠΈΠ³ΠΈΠ΄ΡΠΎΠΊΡΠΈΠ΄Π° Π°Π»ΡΠΌΠΈΠ½ΠΈΡ (Π±Π΅ΠΌΠΈΡΠ°). ΠΠΊΡΠΈΠ΄ ΠΌΠ΅Π΄ΠΈ (I) ΠΎΠΊΠΈΡΠ»ΡΠ΅ΡΡΡ Π΄ΠΎ ΠΎΠΊΡΠΈΠ΄Π° ΠΌΠ΅Π΄ΠΈ
(II) ΠΈ ΠΎΡΠ½ΠΎΠ²Π½ΠΎΠ³ΠΎ ΠΊΠ°ΡΠ±ΠΎΠ½Π°ΡΠ° ΠΌΠ΅Π΄ΠΈ. ΠΡΠΈ Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΌ ΡΡΠ°ΡΠ΅Π½ΠΈΠΈ ΠΎΠΊΡΠΈΠ΄Π° ΠΌΠ΅Π΄ΠΈ (I) ΠΎΠΊΠΈΡΠ»Π΅Π½ΠΈΠ΅ ΠΏΡΠΎΠΈΡΡ
ΠΎΠ΄ΠΈΡ
Π½Π΅ ΠΏΠΎΠ»Π½ΠΎΡΡΡΡ, ΡΠ°ΠΊ ΠΊΠ°ΠΊ ΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΡ ΠΠΈΠ»Π»ΠΈΠ½Π³Π°-ΠΠ΅Π΄Π²ΠΎΡΡΠ°
Π΄Π»Ρ ΠΎΠΊΡΠΈΠ΄Π° ΠΌΠ΅Π΄ΠΈ (II) ΠΈ Π³ΠΈΠ΄ΡΠΎΠΊΡΠΈΠ΄Π° ΠΊΠ°ΡΠ±ΠΎΠ½Π°ΡΠ°
ΠΌΠ΅Π΄ΠΈ Π±ΠΎΠ»ΡΡΠ΅ Π΅Π΄ΠΈΠ½ΠΈΡΡ. Π‘ΡΡΡΠΊΡΡΡΠ° Π²ΡΠ΅Ρ
ΠΌΠ΅Π΄ΡΡΠΎΠ΄Π΅ΡΠΆΠ°ΡΠΈΡ
ΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΠΉ (ΠΎΠΊΡΠΈΠ΄ ΠΌΠ΅Π΄ΠΈ (I), ΠΎΠΊΡΠΈΠ΄ ΠΌΠ΅Π΄ΠΈ
(II), Π³ΠΈΠ΄ΡΠΎΠΊΡΠΈΠ΄ ΠΊΠ°ΡΠ±ΠΎΠ½Π°ΡΠ° ΠΌΠ΅Π΄ΠΈ) ΠΈΠ·ΠΌΠ΅Π½ΡΠ΅ΡΡΡ. ΠΡΠΎ ΠΏΡΠΈΠ²ΠΎΠ΄ΠΈΡ ΠΊ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΡ ΠΊΠ°ΠΊ ΠΌΠ΅ΠΆΠΏΠ»ΠΎΡΠΊΠΎΡΡΠ½ΡΡ
ΡΠ°ΡΡΡΠΎΡΠ½ΠΈΠΉ, ΡΠ°ΠΊ ΠΈ ΡΠ΅ΠΌΠΏΠ΅ΡΠ°ΡΡΡΡ ΡΠ°Π·ΠΎΠ²ΡΡ
ΠΏΡΠ΅Π²ΡΠ°ΡΠ΅Π½ΠΈΠΉ. ΠΠ±Π»Π°ΡΡΡ ΠΊΠΎΠ³Π΅ΡΠ΅Π½ΡΠ½ΠΎΠ³ΠΎ ΡΠ°ΡΡΠ΅ΡΠ½ΠΈΡ (ΠΠΠ )
Π±Π΅ΠΌΠΈΡΠ° ΠΈ ΠΎΠΊΡΠΈΠ΄Π° ΠΌΠ΅Π΄ΠΈ (I) ΡΠΎΡΡΠ°Π²Π»ΡΠ΅Ρ 3β4 Π½ΠΌ ΠΈ 20β30 Π½ΠΌ, ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΠΎ, ΠΈ Π½Π΅ ΠΈΠ·ΠΌΠ΅Π½ΡΠ΅ΡΡΡ ΠΏΡΠΈ
ΠΊΡΠ°ΡΠΊΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΠΌ ΠΈ Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΌ ΡΡΠ°ΡΠ΅Π½ΠΈ
The Role of Targeted Predictors for Nowcasting GDP with Bridge Models: Application to the Euro Area
Molecular basis of USP7 inhibition by selective small-molecule inhibitors
Ubiquitination controls the stability of most cellular proteins, and its deregulation contributes to human diseases including cancer. Deubiquitinases remove ubiquitin from proteins, and their inhibition can induce the degradation of selected proteins, potentially including otherwise 'undruggable' targets. For example, the inhibition of ubiquitin-specific protease 7 (USP7) results in the degradation of the oncogenic E3 ligase MDM2, and leads to re-activation of the tumour suppressor p53 in various cancers. Here we report that two compounds, FT671 and FT827, inhibit USP7 with high affinity and specificity in vitro and within human cells. Co-crystal structures reveal that both compounds target a dynamic pocket near the catalytic centre of the auto-inhibited apo form of USP7, which differs from other USP deubiquitinases. Consistent with USP7 target engagement in cells, FT671 destabilizes USP7 substrates including MDM2, increases levels of p53, and results in the transcription of p53 target genes, induction of the tumour suppressor p21, and inhibition of tumour growth in mice
The impact of a referral card-based intervention on intimate partner violence, psychosocial health, help-seeking and safety behaviour during pregnancy and postpartum: a randomized controlled trial
The treatment of animal manure wastewater by coupled simultaneous methanogenesis and denitrification (SMD) and shortcut nitrification-denitrification (SND)
Sex differences in postural control under unstable conditions in schoolchildren with accelerometric assessment
- β¦